Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration.
Lee
P K
PK
Department of Dermatology, Massachusetts General Hospital, Boston 02114, USA.
Dover
J S
JS
D000152:Acne Vulgaris / Q000139:chemically induced*; D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018237:Germinoma / Q000188:drug therapy / Q000556:secondary; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy; D012008:Recurrence; D013736:Testicular Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D016179:Granulocyte Colony-Stimulating Factor; D005047:Etoposide; D002945:Cisplatin; D007069:Ifosfamide